Delivery Order SPE2DR25D1109-SPE2DR26FFF7M
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,575.44 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus continuous glucose monitoring sensors, with an ultimate completion date of October 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be...
- The Defense Logistics Agency awarded a $4,571.17 delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for Freestyle Libre 3 Plus continuous glucose monitoring sensors. This is a firm fixed price, competitively awarded contract with a completion date of October 24, 2025, and no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $10,186.15 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The sensors will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.32 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, a continuous glucose monitoring device used for diabetes management. The contract is a firm fixed price delivery order with a completion date of September 29, 2025, and was competitively awarded without set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this order. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,568.99 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a firm fixed price, non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,720.12 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of June 9, 2025. This non-compete, firm fixed-price delivery order was issued on June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device distributor supporting federal healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,665.21 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 30, 2025, with an ultimate completion date of October 31, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,781.48 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus continuous glucose monitoring sensors. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of September 10, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $8,393.79 to AmerisourceBergen Drug Corp for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order with a completion date of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical and medical supply distributor for federal healthcare programs, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,424.62 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 24, 2025, with an ultimate completion date of October 27, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF7MDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,810.31 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Freestyle Libre 3 Plus continuous glucose monitoring sensors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract that runs through December 2026 and serves as the company's comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen was competitively selected to fulfill this medical supply requirement through open competition. The company's extensive federal contract portfolio with DLA demonstrates its established capability to deliver a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including specialty medications, medical devices, and healthcare commodities across multiple therapeutic domains. This delivery order for glucose monitoring sensors supports DLA's mission to supply medical necessities to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 10/29/25 |